Cargando…

Hospital preparations of ethanol-free furosemide oral solutions: Formulation and stability study

Furosemide is a diuretic frequently used in the therapeutic management of edema associated with cardiac, renal, and hepatic failure and hypertension. However, there are a very low number of pharmaceutical dosage forms containing furosemide that are suitable for children under 6- years old. Therefore...

Descripción completa

Detalles Bibliográficos
Autores principales: Sombié, Charles Bavouma, Guetambaba, J. E. Kéré, Diawara, Hermine Zimé, Yaméogo, Josias, Ouédraogo, Salfo, Goole, Jonathan, Semdé, Rasmané
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9022368/
https://www.ncbi.nlm.nih.gov/pubmed/35464657
http://dx.doi.org/10.4103/japtr.japtr_325_21
_version_ 1784690067466354688
author Sombié, Charles Bavouma
Guetambaba, J. E. Kéré
Diawara, Hermine Zimé
Yaméogo, Josias
Ouédraogo, Salfo
Goole, Jonathan
Semdé, Rasmané
author_facet Sombié, Charles Bavouma
Guetambaba, J. E. Kéré
Diawara, Hermine Zimé
Yaméogo, Josias
Ouédraogo, Salfo
Goole, Jonathan
Semdé, Rasmané
author_sort Sombié, Charles Bavouma
collection PubMed
description Furosemide is a diuretic frequently used in the therapeutic management of edema associated with cardiac, renal, and hepatic failure and hypertension. However, there are a very low number of pharmaceutical dosage forms containing furosemide that are suitable for children under 6- years old. Therefore, there is a real need to develop hospital preparations, especially in the hospital. Four oral pediatric solutions of furosemide (2 mg/Ml) were formulated. Two of those solutions did not contain ethanol. For each formulation, 12 batches of 1600.0 Ml were prepared and packaged in 250.0 Ml brown glass bottles with polypropylene screw caps. The physicochemical properties (visual appearance, pH, osmolarity, drug content) and microbiological quality of the finished product were determined on the freshly prepared solutions and after 90 days of storage at 30°C/65% RH. The physicochemical and microbiological characteristics of the freshly prepared solutions were within the prescribed specifications. After 90 days of storage at 30°C/65% RH, the solutions containing sucrose and those without ethanol showed a slight decrease in pH and furosemide content of about 2.5%–4.5% (w/w). Despite this slight decrease, the characteristics remained within the prescribed specifications. Based on the stability profile of the ethanol-free solution containing sorbitol, it could be implemented in hospitals for the care of pediatric patients.
format Online
Article
Text
id pubmed-9022368
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-90223682022-04-22 Hospital preparations of ethanol-free furosemide oral solutions: Formulation and stability study Sombié, Charles Bavouma Guetambaba, J. E. Kéré Diawara, Hermine Zimé Yaméogo, Josias Ouédraogo, Salfo Goole, Jonathan Semdé, Rasmané J Adv Pharm Technol Res Original Article Furosemide is a diuretic frequently used in the therapeutic management of edema associated with cardiac, renal, and hepatic failure and hypertension. However, there are a very low number of pharmaceutical dosage forms containing furosemide that are suitable for children under 6- years old. Therefore, there is a real need to develop hospital preparations, especially in the hospital. Four oral pediatric solutions of furosemide (2 mg/Ml) were formulated. Two of those solutions did not contain ethanol. For each formulation, 12 batches of 1600.0 Ml were prepared and packaged in 250.0 Ml brown glass bottles with polypropylene screw caps. The physicochemical properties (visual appearance, pH, osmolarity, drug content) and microbiological quality of the finished product were determined on the freshly prepared solutions and after 90 days of storage at 30°C/65% RH. The physicochemical and microbiological characteristics of the freshly prepared solutions were within the prescribed specifications. After 90 days of storage at 30°C/65% RH, the solutions containing sucrose and those without ethanol showed a slight decrease in pH and furosemide content of about 2.5%–4.5% (w/w). Despite this slight decrease, the characteristics remained within the prescribed specifications. Based on the stability profile of the ethanol-free solution containing sorbitol, it could be implemented in hospitals for the care of pediatric patients. Wolters Kluwer - Medknow 2022 2022-04-07 /pmc/articles/PMC9022368/ /pubmed/35464657 http://dx.doi.org/10.4103/japtr.japtr_325_21 Text en Copyright: © 2022 Journal of Advanced Pharmaceutical Technology & Research https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Original Article
Sombié, Charles Bavouma
Guetambaba, J. E. Kéré
Diawara, Hermine Zimé
Yaméogo, Josias
Ouédraogo, Salfo
Goole, Jonathan
Semdé, Rasmané
Hospital preparations of ethanol-free furosemide oral solutions: Formulation and stability study
title Hospital preparations of ethanol-free furosemide oral solutions: Formulation and stability study
title_full Hospital preparations of ethanol-free furosemide oral solutions: Formulation and stability study
title_fullStr Hospital preparations of ethanol-free furosemide oral solutions: Formulation and stability study
title_full_unstemmed Hospital preparations of ethanol-free furosemide oral solutions: Formulation and stability study
title_short Hospital preparations of ethanol-free furosemide oral solutions: Formulation and stability study
title_sort hospital preparations of ethanol-free furosemide oral solutions: formulation and stability study
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9022368/
https://www.ncbi.nlm.nih.gov/pubmed/35464657
http://dx.doi.org/10.4103/japtr.japtr_325_21
work_keys_str_mv AT sombiecharlesbavouma hospitalpreparationsofethanolfreefurosemideoralsolutionsformulationandstabilitystudy
AT guetambabajekere hospitalpreparationsofethanolfreefurosemideoralsolutionsformulationandstabilitystudy
AT diawaraherminezime hospitalpreparationsofethanolfreefurosemideoralsolutionsformulationandstabilitystudy
AT yameogojosias hospitalpreparationsofethanolfreefurosemideoralsolutionsformulationandstabilitystudy
AT ouedraogosalfo hospitalpreparationsofethanolfreefurosemideoralsolutionsformulationandstabilitystudy
AT goolejonathan hospitalpreparationsofethanolfreefurosemideoralsolutionsformulationandstabilitystudy
AT semderasmane hospitalpreparationsofethanolfreefurosemideoralsolutionsformulationandstabilitystudy